Cargando…
Comparing pentafecta outcomes between nerve sparing and non nerve sparing robot-assisted radical prostatectomy in a propensity score-matched study
Pentafecta (continence, potency, cancer control, free surgical margins, and no complications) is an important outcome of prostatectomy. Our objective was to assess the pentafecta achievement between nerve-spring and non-nerve-sparing robot-assisted radical prostatectomy (RARP) in a large single-cent...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10517009/ https://www.ncbi.nlm.nih.gov/pubmed/37740045 http://dx.doi.org/10.1038/s41598-023-43092-z |
_version_ | 1785109244792537088 |
---|---|
author | Bejrananda, Tanan Takahara, Kiyoshi Sowanthip, Dutsadee Motonaga, Tomonari Yagi, Kota Nakamura, Wataru Saruta, Masanobu Nukaya, Takuhisa Takenaka, Masashi Zennami, Kenji Ichino, Manabu Sasaki, Hitomi Sumitomo, Makoto Shiroki, Ryoichi |
author_facet | Bejrananda, Tanan Takahara, Kiyoshi Sowanthip, Dutsadee Motonaga, Tomonari Yagi, Kota Nakamura, Wataru Saruta, Masanobu Nukaya, Takuhisa Takenaka, Masashi Zennami, Kenji Ichino, Manabu Sasaki, Hitomi Sumitomo, Makoto Shiroki, Ryoichi |
author_sort | Bejrananda, Tanan |
collection | PubMed |
description | Pentafecta (continence, potency, cancer control, free surgical margins, and no complications) is an important outcome of prostatectomy. Our objective was to assess the pentafecta achievement between nerve-spring and non-nerve-sparing robot-assisted radical prostatectomy (RARP) in a large single-center cohort. The study included 1674 patients treated with RARP between August 2009 and November 2022 to assess the clinical outcomes. Cox regression analyses were performed to evaluate the prognostic significance of RARP for pentafecta achievement, and 1:1 propensity score matching (PSM) was performed between the nerve-sparing and non-nerve-sparing to test the validity of the results. Pentafecta definition included continence, which was defined as the use of zero pads; potency, which was defined as the ability to achieve and maintain satisfactory erections or ones firm enough for sexual activity and sexual intercourse. The biochemical recurrence rate was defined as two consecutive PSA levels > 0.2 ng/mL after RARP; 90-day Clavien–Dindo complications ≤ 3a; and a negative surgical pathologic margin. The median follow-up period was 61.3 months (IQR 6–159 months). A multivariate Cox regression analysis demonstrated that pentafecta achievement was significantly associated with nerve-sparing (NS) approach (1188 patients) (OR 4.16; 95% CI 2.51–6.9), p < 0.001), unilateral nerve preservation (983 patients) (OR 3.83; 95% CI 2.31–6.37, p < 0.001) and bilateral nerve preservation (205 patients) (OR 7.43; 95% CI 4.14–13.36, p < 0.001). After propensity matching, pentafecta achievement rates in the NS (476 patients) and non-NS (476 patients) groups were 72 (15.1%) and 19 (4%), respectively. (p < 0.001). NS in RARP offers a superior advantage in pentafecta achievement compared with non-NS RARP. This validation study provides the pentafecta outcome after RARP associated with nerve-sparing in clinical practice. |
format | Online Article Text |
id | pubmed-10517009 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-105170092023-09-24 Comparing pentafecta outcomes between nerve sparing and non nerve sparing robot-assisted radical prostatectomy in a propensity score-matched study Bejrananda, Tanan Takahara, Kiyoshi Sowanthip, Dutsadee Motonaga, Tomonari Yagi, Kota Nakamura, Wataru Saruta, Masanobu Nukaya, Takuhisa Takenaka, Masashi Zennami, Kenji Ichino, Manabu Sasaki, Hitomi Sumitomo, Makoto Shiroki, Ryoichi Sci Rep Article Pentafecta (continence, potency, cancer control, free surgical margins, and no complications) is an important outcome of prostatectomy. Our objective was to assess the pentafecta achievement between nerve-spring and non-nerve-sparing robot-assisted radical prostatectomy (RARP) in a large single-center cohort. The study included 1674 patients treated with RARP between August 2009 and November 2022 to assess the clinical outcomes. Cox regression analyses were performed to evaluate the prognostic significance of RARP for pentafecta achievement, and 1:1 propensity score matching (PSM) was performed between the nerve-sparing and non-nerve-sparing to test the validity of the results. Pentafecta definition included continence, which was defined as the use of zero pads; potency, which was defined as the ability to achieve and maintain satisfactory erections or ones firm enough for sexual activity and sexual intercourse. The biochemical recurrence rate was defined as two consecutive PSA levels > 0.2 ng/mL after RARP; 90-day Clavien–Dindo complications ≤ 3a; and a negative surgical pathologic margin. The median follow-up period was 61.3 months (IQR 6–159 months). A multivariate Cox regression analysis demonstrated that pentafecta achievement was significantly associated with nerve-sparing (NS) approach (1188 patients) (OR 4.16; 95% CI 2.51–6.9), p < 0.001), unilateral nerve preservation (983 patients) (OR 3.83; 95% CI 2.31–6.37, p < 0.001) and bilateral nerve preservation (205 patients) (OR 7.43; 95% CI 4.14–13.36, p < 0.001). After propensity matching, pentafecta achievement rates in the NS (476 patients) and non-NS (476 patients) groups were 72 (15.1%) and 19 (4%), respectively. (p < 0.001). NS in RARP offers a superior advantage in pentafecta achievement compared with non-NS RARP. This validation study provides the pentafecta outcome after RARP associated with nerve-sparing in clinical practice. Nature Publishing Group UK 2023-09-22 /pmc/articles/PMC10517009/ /pubmed/37740045 http://dx.doi.org/10.1038/s41598-023-43092-z Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Bejrananda, Tanan Takahara, Kiyoshi Sowanthip, Dutsadee Motonaga, Tomonari Yagi, Kota Nakamura, Wataru Saruta, Masanobu Nukaya, Takuhisa Takenaka, Masashi Zennami, Kenji Ichino, Manabu Sasaki, Hitomi Sumitomo, Makoto Shiroki, Ryoichi Comparing pentafecta outcomes between nerve sparing and non nerve sparing robot-assisted radical prostatectomy in a propensity score-matched study |
title | Comparing pentafecta outcomes between nerve sparing and non nerve sparing robot-assisted radical prostatectomy in a propensity score-matched study |
title_full | Comparing pentafecta outcomes between nerve sparing and non nerve sparing robot-assisted radical prostatectomy in a propensity score-matched study |
title_fullStr | Comparing pentafecta outcomes between nerve sparing and non nerve sparing robot-assisted radical prostatectomy in a propensity score-matched study |
title_full_unstemmed | Comparing pentafecta outcomes between nerve sparing and non nerve sparing robot-assisted radical prostatectomy in a propensity score-matched study |
title_short | Comparing pentafecta outcomes between nerve sparing and non nerve sparing robot-assisted radical prostatectomy in a propensity score-matched study |
title_sort | comparing pentafecta outcomes between nerve sparing and non nerve sparing robot-assisted radical prostatectomy in a propensity score-matched study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10517009/ https://www.ncbi.nlm.nih.gov/pubmed/37740045 http://dx.doi.org/10.1038/s41598-023-43092-z |
work_keys_str_mv | AT bejranandatanan comparingpentafectaoutcomesbetweennervesparingandnonnervesparingrobotassistedradicalprostatectomyinapropensityscorematchedstudy AT takaharakiyoshi comparingpentafectaoutcomesbetweennervesparingandnonnervesparingrobotassistedradicalprostatectomyinapropensityscorematchedstudy AT sowanthipdutsadee comparingpentafectaoutcomesbetweennervesparingandnonnervesparingrobotassistedradicalprostatectomyinapropensityscorematchedstudy AT motonagatomonari comparingpentafectaoutcomesbetweennervesparingandnonnervesparingrobotassistedradicalprostatectomyinapropensityscorematchedstudy AT yagikota comparingpentafectaoutcomesbetweennervesparingandnonnervesparingrobotassistedradicalprostatectomyinapropensityscorematchedstudy AT nakamurawataru comparingpentafectaoutcomesbetweennervesparingandnonnervesparingrobotassistedradicalprostatectomyinapropensityscorematchedstudy AT sarutamasanobu comparingpentafectaoutcomesbetweennervesparingandnonnervesparingrobotassistedradicalprostatectomyinapropensityscorematchedstudy AT nukayatakuhisa comparingpentafectaoutcomesbetweennervesparingandnonnervesparingrobotassistedradicalprostatectomyinapropensityscorematchedstudy AT takenakamasashi comparingpentafectaoutcomesbetweennervesparingandnonnervesparingrobotassistedradicalprostatectomyinapropensityscorematchedstudy AT zennamikenji comparingpentafectaoutcomesbetweennervesparingandnonnervesparingrobotassistedradicalprostatectomyinapropensityscorematchedstudy AT ichinomanabu comparingpentafectaoutcomesbetweennervesparingandnonnervesparingrobotassistedradicalprostatectomyinapropensityscorematchedstudy AT sasakihitomi comparingpentafectaoutcomesbetweennervesparingandnonnervesparingrobotassistedradicalprostatectomyinapropensityscorematchedstudy AT sumitomomakoto comparingpentafectaoutcomesbetweennervesparingandnonnervesparingrobotassistedradicalprostatectomyinapropensityscorematchedstudy AT shirokiryoichi comparingpentafectaoutcomesbetweennervesparingandnonnervesparingrobotassistedradicalprostatectomyinapropensityscorematchedstudy |